| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4dac022280ec96f54c694eb427655932 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-255
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-54 |
| filingDate |
2002-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b944a1a3deffbb48df40657ed9b7431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7a0e78233550f6884761d9d8f93833be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_56c1cf180ba3a81c7ad2ae7894980363
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03980b4f53f8922b4cbfc1a5f30953f2 |
| publicationDate |
2003-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03020263-A1 |
| titleOfInvention |
Use of c2-substituted indane-1-ol systems for producing medicaments for the prophylaxis or treatment of obesity |
| abstract |
The invention relates to the use of C2-substituted indane-1-ol systems and to their physiologically compatible salts and physiologically functional derivatives for producing medicaments to promote weight loss in mammals and for the prophylaxis or treatment of obesity. The invention also relates to the use of compounds of formula (I), wherein the groups are defined as per the description, and to the physiologically compatible salts and physiologically functional derivatives of said compounds, for producing a medicament for the prophylaxis or treatment of obesity. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6982353-B2 |
| priorityDate |
2001-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |